Therapies for Cardiovascular Aging
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT07219511
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2025
Completion: Jul 31, 2026
Loading map...